(Q38098442)

28 August 2017

title

11C-choline PET/CT and PSA kinetics (English)

1 reference

28 August 2017

Maria Picchio

2

0 references

author name string

Paolo Castellucci

series ordinal

1

1 reference

28 August 2017

publication date

12 April 2013

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

28 August 2017

published in

1 reference

28 August 2017

volume

40 Suppl 1

1 reference

28 August 2017

page(s)

S36-40

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-013-2377-z

28 August 2017

exact match

0 references

cites work

Efficacy of prostatic fossa biopsy in detecting local recurrence after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2377-Z

Predictors of metastatic disease in men with biochemical failure following radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2377-Z

Novel tracers and their development for the imaging of metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2377-Z

11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2377-Z

Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2377-Z

The detection rate of [11C]choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2377-Z

Predictive factors of [(11)C]choline PET/CT in patients with biochemical failure after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2377-Z

Influence of trigger PSA and PSA kinetics on 11C-Choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2377-Z

PSA doubling time for prediction of [(11)C]choline PET/CT findings in prostate cancer patients with biochemical failure after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2377-Z

Is there a role for ¹¹C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2377-Z

Impact of total PSA, PSA doubling time and PSA velocity on detection rates of 11C-Choline positron emission tomography in recurrent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2377-Z

Relationship between PSA kinetics and [18F]fluorocholine PET/CT detection rates of recurrence in patients with prostate cancer after total prostatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2377-Z

Multiple vesico-urethral biopsies following radical prostatectomy: the predictive roles of TRUS, DRE, PSA and the pathological stage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2377-Z

The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2377-Z

Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2377-Z

Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2377-Z

Clinical impact of 18F-choline PET/CT in patients with recurrent prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2377-Z

Clinical evidence on PET/CT for radiation therapy planning in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2377-Z

[18F]fluoroethylcholine-PET/CT imaging for radiation treatment planning of recurrent and primary prostate cancer with dose escalation to PET/CT-positive lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2377-Z

Pelvic/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C]choline positron emission tomography/computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2377-Z

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2377-Z

Lymph nodal metastases: diagnosis and treatment

21 January 2018

1 reference

12 December 2020

Influence of PSA, PSA velocity and PSA doubling time on contrast-enhanced 18F-choline PET/CT detection rate in patients with rising PSA after radical prostatectomy

1 reference

12 December 2020

A model that predicts the probability of positive imaging in prostate cancer cases with biochemical failure after initial definitive local therapy

1 reference

12 December 2020

Radionuclide bone scintigraphy in patients with biochemical recurrence after radical prostatectomy: when is it indicated?

1 reference

12 December 2020

Correlation of [11C]choline PET-CT with time to treatment and disease-specific survival in men with recurrent prostate cancer after radical prostatectomy

1 reference

12 December 2020

Influence of 11C-choline PET/CT on the treatment planning for salvage radiation therapy in patients with biochemical recurrence of prostate cancer

1 reference

12 December 2020

Overall survival after prostate-specific-antigen-detected recurrence following conformal radiation therapy

1 reference

12 December 2020

Detection and localization of prostate cancer: correlation of (11)C-choline PET/CT with histopathologic step-section analysis

1 reference

12 December 2020

Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy

1 reference

12 December 2020

10.1007/S00259-013-2377-Z

Identifiers

DOI

1 reference

28 August 2017

1 reference